Breast or ovarian cancers. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Breast Cell Line, Tumor Tumor Cells, Cultured Ovary Neoplastic Stem Cells MCF-7 Cells Epithelial Cells Mammary Glands, Human Axilla Nipples Lymph Nodes Spheroids, Cellular

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases56

Ovarian Neoplasms Neoplasms, Glandular and Epithelial Carcinoma, Ductal, Breast Breast Diseases Cystadenocarcinoma, Serous Neoplasm Invasiveness Carcinoma Neoplasm Metastasis Breast Neoplasms Breast Neoplasms, Male Genetic Predisposition to Disease Adenocarcinoma, Clear Cell Adenocarcinoma, Mucinous Prostatic Neoplasms Neoplasms Carcinoma, Endometrioid Neoplasm Recurrence, Local Lung Neoplasms Peritoneal Neoplasms Disease Progression Ascites Colonic Neoplasms Fibrocystic Breast Disease Stomach Neoplasms Endometrial Neoplasms Carcinoma, Intraductal, Noninfiltrating Cystadenocarcinoma Carcinoma, Lobular Pancreatic Neoplasms Cell Transformation, Neoplastic Fallopian Tube Neoplasms Adenocarcinoma Uterine Cervical Neoplasms Hereditary Breast and Ovarian Cancer Syndrome Neoplasms, Hormone-Dependent Neovascularization, Pathologic Mammary Neoplasms, Experimental Neoplasms, Cystic, Mucinous, and Serous Colorectal Neoplasms Neoplastic Syndromes, Hereditary Genital Neoplasms, Female Neoplasms, Second Primary Carcinoma, Squamous Cell Cystadenocarcinoma, Mucinous Carcinoma, Non-Small-Cell Lung Urinary Bladder Neoplasms Carcinoma in Situ Neoplasms, Multiple Primary Bone Neoplasms Lymphatic Metastasis Cystadenoma, Serous Rectal Neoplasms Fibroadenoma Precancerous Conditions Adenocarcinoma, Papillary Carcinoma, Ductal

Chemicals and Drugs54

CA-125 Antigen Tumor Markers, Biological Antineoplastic Agents Receptors, Estrogen BRCA2 Protein Neoplasm Proteins BRCA1 Protein Receptor, erbB-2 Cisplatin Receptors, Progesterone Paclitaxel Tamoxifen RNA, Messenger Antineoplastic Agents, Phytogenic DNA, Neoplasm RNA, Small Interfering Antineoplastic Agents, Hormonal Carboplatin Epididymal Secretory Proteins Tumor Suppressor Protein p53 Antigens, Neoplasm Cancer Vaccines Estrogens Antibodies, Monoclonal Taxoids Estrogen Receptor alpha RNA, Neoplasm Tumor Suppressor Proteins Platinum Compounds Transcription Factors Receptor, Epidermal Growth Factor Platinum Antibodies, Monoclonal, Humanized Fluorouracil MicroRNAs Antigens, Tumor-Associated, Carbohydrate Mucin-1 DNA-Binding Proteins Cyclophosphamide Topotecan Proto-Oncogene Proteins c-akt Contraceptives, Oral Estrogen Antagonists Nuclear Proteins Proto-Oncogene Proteins Ki-67 Antigen Anticarcinogenic Agents Antibiotics, Antineoplastic Estradiol Deoxycytidine Aromatase Inhibitors Organoplatinum Compounds DNA Primers Protein-Serine-Threonine Kinases

Analytical, Diagnostic and Therapeutic Techniques and Equipment70

Prognosis Early Detection of Cancer Neoplasm Staging Mammography Antineoplastic Combined Chemotherapy Protocols Survival Analysis Risk Factors Reverse Transcriptase Polymerase Chain Reaction Xenograft Model Antitumor Assays Gene Expression Profiling Survival Rate Immunohistochemistry Disease-Free Survival Risk Case-Control Studies Follow-Up Studies Prospective Studies Retrospective Studies Blotting, Western Chemotherapy, Adjuvant Neoplasm Transplantation Mastectomy Risk Assessment Sensitivity and Specificity Odds Ratio Breast Self-Examination Genetic Testing Transplantation, Heterologous Treatment Outcome Oligonucleotide Array Sequence Analysis Registries Breast Implants Tissue Array Analysis Kaplan-Meier Estimate Multivariate Analysis Incidence Drug Screening Assays, Antitumor Cohort Studies Tumor Burden Neoplasm Grading Polymerase Chain Reaction Transfection Reproducibility of Results Predictive Value of Tests Mammary Neoplasms, Experimental Questionnaires Logistic Models SEER Program Immunoenzyme Techniques Drug Administration Schedule Combined Modality Therapy DNA Mutational Analysis Confidence Intervals Ultrasonography, Mammary Gene Knockdown Techniques Clinical Trials as Topic Molecular Targeted Therapy Mastectomy, Segmental Models, Biological Mammaplasty Reproductive History Salpingectomy Biopsy, Needle Mass Screening Biopsy Enzyme-Linked Immunosorbent Assay Radiotherapy, Adjuvant Proportional Hazards Models Flow Cytometry Radiotherapy

Psychiatry and Psychology3

Breast Feeding Breast Self-Examination Smoking

Phenomena and Processes50

Genes, BRCA1 Gene Expression Regulation, Neoplastic Drug Resistance, Neoplasm Genes, BRCA2 Breast Feeding Genetic Predisposition to Disease Cell Proliferation Risk Germ-Line Mutation Mutation Apoptosis Sensitivity and Specificity Odds Ratio Postmenopause DNA Methylation Signal Transduction Cell Movement Cell Division Genotype Down-Regulation Cell Growth Processes Menopause Up-Regulation Transfection Premenopause Time Factors Genes, Tumor Suppressor Dose-Response Relationship, Drug Cell Cycle Promoter Regions, Genetic Polymorphism, Genetic RNA Interference Cell Survival Gene Silencing Heterozygote Gene Expression Genes, erbB-2 Parity Base Sequence Gene Amplification Genes, Neoplasm Drug Synergism Genes, p53 Phenotype Alleles Phosphorylation Loss of Heterozygosity Epithelial-Mesenchymal Transition Tumor Microenvironment Diet

Disciplines and Occupations3

Immunohistochemistry Medical Oncology Genetic Counseling

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Humanities1

Quality of Life

Information Science7

Survival Rate Registries Incidence Questionnaires SEER Program Base Sequence Molecular Sequence Data

Named Groups3

Survivors Jews European Continental Ancestry Group

Health Care34

Survival Analysis Risk Factors Survival Rate Disease-Free Survival Risk Case-Control Studies Follow-Up Studies Prospective Studies Retrospective Studies Risk Assessment Sensitivity and Specificity Odds Ratio Genetic Testing Age Factors Treatment Outcome Registries Kaplan-Meier Estimate Multivariate Analysis Incidence Cohort Studies Reproducibility of Results Predictive Value of Tests Questionnaires Logistic Models SEER Program Confidence Intervals Clinical Trials as Topic Parity Genetic Counseling National Cancer Institute (U.S.)Family Health Reproductive History Mass Screening Proportional Hazards Models

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Ovarian Neoplasms Breast Neoplasms, Glandular and Epithelial Carcinoma, Ductal, Breast Cell Line, Tumor Breast Diseases CA-125 Antigen Genes, BRCA1 Cystadenocarcinoma, Serous Gene Expression Regulation, Neoplastic Tumor Markers, Biological Neoplasm Invasiveness Carcinoma Antineoplastic Agents Prognosis Early Detection of Cancer Drug Resistance, Neoplasm Neoplasm Staging Genes, BRCA2 Mice, Nude Receptors, Estrogen Neoplasm Metastasis BRCA2 Protein Neoplasm Proteins Breast Neoplasms Breast Feeding BRCA1 Protein Receptor, erbB-2 Breast Neoplasms, Male Genetic Predisposition to Disease Mammography Antineoplastic Combined Chemotherapy Protocols Survival Analysis Cisplatin Tumor Cells, Cultured Risk Factors Adenocarcinoma, Clear Cell Receptors, Progesterone Paclitaxel Reverse Transcriptase Polymerase Chain Reaction Xenograft Model Antitumor Assays Cell Proliferation Gene Expression Profiling Tamoxifen Adenocarcinoma, Mucinous Survival Rate Prostatic Neoplasms Neoplasms Immunohistochemistry Carcinoma, Endometrioid Neoplasm Recurrence, Local Disease-Free Survival Lung Neoplasms RNA, Messenger Risk Germ-Line Mutation Peritoneal Neoplasms Disease Progression Mutation Ascites Case-Control Studies Antineoplastic Agents, Phytogenic DNA, Neoplasm Follow-Up Studies Prospective Studies Apoptosis Retrospective Studies Blotting, Western Colonic Neoplasms Fibrocystic Breast Disease RNA, Small Interfering Chemotherapy, Adjuvant Neoplasm Transplantation Mastectomy Antineoplastic Agents, Hormonal Risk Assessment Sensitivity and Specificity Carboplatin Stomach Neoplasms Odds Ratio Breast Self-Examination Postmenopause Genetic Testing Age Factors Endometrial Neoplasms Transplantation, Heterologous Treatment Outcome Oligonucleotide Array Sequence Analysis Carcinoma, Intraductal, Noninfiltrating Epididymal Secretory Proteins Cystadenocarcinoma DNA Methylation Signal Transduction Tumor Suppressor Protein p53 Antigens, Neoplasm Cell Movement Cancer Vaccines Registries Breast Implants Tissue Array Analysis

No FAQ available that match "breast or ovarian cancers"